NovaBay Pharmaceuticals
$1.43
94
-$0.05-3.38% Friday 19:51
Statistics
Day High
1.54
Day Low
1.41
52W High
95.8
52W Low
1.16
Volume
115,919
Avg. Volume
-
Mkt Cap
180.2M
P/E Ratio
-
Dividend Yield
279.72%
Dividend
4
Upcoming
Dividends
279.72%Dividend Yield
Sep 25
$4
Sep 25
$4
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
6AugExpected
Expected EPS
-0.55
Actual EPS
N/A
Financials
-88.01%Profit Margin
Unprofitable19.56MRevenue
-17.22MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NBY. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Ocular Therapeutix
OCUL
Mkt Cap1.8B
National Vision
EYE
Mkt Cap1.37B
Alcon
ALC
Mkt Cap33.06B
Johnson & Johnson
JNJ
Mkt Cap564.11B
Pfizer
PFE
Mkt Cap147.62B
Novartis
NVS
Mkt Cap290.05B
Bausch Health Companies
BHC
Mkt Cap2.04B
Regeneron Pharmaceuticals
REGN
Mkt Cap66.98B
Abbvie
ABBV
Mkt Cap381.1B
About
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Show more...
CEO
Mr. Michael Kazley
Employees
13
Country
United States
ISIN
US66987P2011
Listings
0 Comments
Share your thoughts
FAQ
What is NovaBay Pharmaceuticals stock price today?▼
The current price of NBY is $1.43 USD — it has decreased by -3.38% in the past 24 hours. Watch NovaBay Pharmaceuticals stock price performance more closely on the chart.
What is NovaBay Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NovaBay Pharmaceuticals stocks are traded under the ticker NBY.
Is NovaBay Pharmaceuticals stock price growing?▼
NBY stock has fallen by -7.74% compared to the previous week, the month change is a +7.52% rise, over the last year NovaBay Pharmaceuticals has showed a -49.8% decrease.
What is NovaBay Pharmaceuticals market cap?▼
Today NovaBay Pharmaceuticals has the market capitalization of 180.2M
When is the next NovaBay Pharmaceuticals earnings date?▼
NovaBay Pharmaceuticals is going to release the next earnings report on August 06, 2026.
What is NovaBay Pharmaceuticals revenue for the last year?▼
NovaBay Pharmaceuticals revenue for the last year amounts to 19.56M USD.
What is NovaBay Pharmaceuticals net income for the last year?▼
NBY net income for the last year is -17.22M USD.
Does NovaBay Pharmaceuticals pay dividends?▼
Yes, NBY dividends are paid en. The last dividend per share was 4 USD. As of today, Dividend Yield (FWD)% is 279.72%.
How many employees does NovaBay Pharmaceuticals have?▼
As of May 26, 2026, the company has 13 employees.
In which sector is NovaBay Pharmaceuticals located?▼
NovaBay Pharmaceuticals operates in the Health & Wellness sector.
When did NovaBay Pharmaceuticals complete a stock split?▼
The last stock split for NovaBay Pharmaceuticals was on February 23, 2026 with a ratio of 1:5.
Where is NovaBay Pharmaceuticals headquartered?▼
NovaBay Pharmaceuticals is headquartered in Emeryville, United States.